{"id":"W2470583568","doi":"10.1093/annonc/mdw265","title":"Effect of nivolumab on health-related quality of life in patients with treatment-naïve advanced melanoma: results from the phase III CheckMate 066 study","year":2016,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":118,"is_retracted":false,"has_abstract":false,"ca_institutions":"BC Cancer Agency; University of British Columbia","funders":"Flatiron Health; Helsinn; Genentech; Celgene; Amgen; Pfizer; Bristol-Myers Squibb; GlaxoSmithKline","keywords":"Medicine; Nivolumab; Quality of life (healthcare); Phases of clinical research; Internal medicine; Oncology; Cancer; Nursing; Immunotherapy; Chemotherapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001213676,0.0001593645,0.001074244,0.0000777714,0.0000252601,8.165003e-7,0.0001014508,0.0000927318,0.00003639769],"category_scores_gemma":[0.0003042216,0.00007368573,0.0001106619,0.0001840722,0.0001894247,0.00003643073,0.00001684232,0.00007266123,0.000001724265],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001229138,"about_ca_system_score_gemma":0.0002613828,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00788762,"about_ca_topic_score_gemma":0.001319498,"domain_scores_codex":[0.9974143,0.0008281514,0.001086493,0.0002484237,0.0002217352,0.0002009313],"domain_scores_gemma":[0.9969943,0.001346652,0.001037751,0.0004306723,0.0001288785,0.00006178869],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"observational","study_design_scores_codex":[0.4791871,0.007591228,0.1170566,0.00003784143,0.0009142449,0.000005621946,0.002490555,0.000001817358,0.002209469,0.000003387709,0.0002928126,0.3902093],"study_design_scores_gemma":[0.2216324,0.1883689,0.5785328,0.0002906951,0.00005847872,3.334852e-7,0.0002709368,0.000001158562,0.01035236,0.000008325129,0.0004081392,0.00007546952],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9943293,0.0005246093,7.054916e-7,0.002978251,0.0000841298,0.001519086,0.0002988017,0.000009084216,0.0002559766],"genre_scores_gemma":[0.9993253,0.0002508009,0.00001020483,0.0002554393,0.00001280354,0.00003370867,0.00004614165,0.00001162483,0.00005391194],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4614762,"threshold_uncertainty_score":0.9987189,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05874758653918304,"score_gpt":0.4089947964497547,"score_spread":0.3502472099105717,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}